Financials Med Life S.A.

Equities

M

ROMEDLACNOR6

Healthcare Facilities & Services

End-of-day quote Bucharest S.E. 23:00:00 01/05/2024 BST 5-day change 1st Jan Change
4.2 RON +1.69% Intraday chart for Med Life S.A. +2.07% +5.53%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 745.3 1,473 3,143 2,223 2,094 2,210 - -
Enterprise Value (EV) 1 1,259 2,065 3,739 3,320 3,148 2,210 2,210 2,210
P/E ratio 44.1 x 27.2 x - - - 105 x 70 x -
Yield - - - - - - - -
Capitalization / Revenue 0.77 x 1.37 x 2.2 x 1.23 x 0.95 x 0.89 x 0.8 x -
EV / Revenue 0.77 x 1.37 x 2.2 x 1.23 x 0.95 x 0.89 x 0.8 x -
EV / EBITDA 4.98 x 6.56 x 10.2 x 8.74 x 7.29 x 6.92 x 6.26 x -
EV / FCF 12.4 x 32.4 x 24.8 x -7.89 x - 8.6 x 9.85 x 7.27 x
FCF Yield 8.04% 3.08% 4.04% -12.7% - 11.6% 10.2% 13.8%
Price to Book 4.02 x 6.16 x 9.39 x 5.38 x 4.25 x 4.29 x 4.08 x -
Nbr of stocks (in thousands) 526,105 526,105 526,105 526,105 526,105 526,105 - -
Reference price 2 1.417 2.800 5.975 4.225 3.980 4.200 4.200 4.200
Announcement Date 21/02/20 26/02/21 25/02/22 24/02/23 29/02/24 - - -
1RON in Million2RON
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 967.4 1,078 1,432 1,806 2,210 2,491 2,779 -
EBITDA 1 149.7 224.6 308.4 254.2 287.1 319.2 352.9 -
EBIT 1 56.37 119.8 187.2 102.7 91.52 155.9 181.2 187
Operating Margin 5.83% 11.11% 13.07% 5.69% 4.14% 6.26% 6.52% -
Earnings before Tax (EBT) 1 29.02 78.81 141.1 - - 26.8 35.89 -
Net income 1 17.09 54.62 - - - 22.51 30.15 -
Net margin 1.77% 5.07% - - - 0.9% 1.08% -
EPS 2 0.0322 0.1028 - - - 0.0400 0.0600 -
Free Cash Flow 1 59.96 45.43 126.8 -281.9 - 256.8 224.3 303.9
FCF margin 6.2% 4.21% 8.86% -15.61% - 10.31% 8.07% -
FCF Conversion (EBITDA) 40.06% 20.23% 41.14% - - 80.45% 63.55% -
FCF Conversion (Net income) 350.86% 83.18% - - - 1,140.83% 743.95% -
Dividend per Share - - - - - - - -
Announcement Date 21/02/20 26/02/21 25/02/22 24/02/23 29/02/24 - - -
1RON in Million2RON
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 S1 2021 Q3 2022 Q1 2022 Q2 2022 S1 2022 Q3
Net sales 1 677.3 368.9 420.9 439.5 860.4 469.2
EBITDA 1 155.9 69.42 - 63.5 135.7 62.39
EBIT 1 103.1 42.95 - 28.32 69.18 26.26
Operating Margin 15.23% 11.64% - 6.44% 8.04% 5.6%
Earnings before Tax (EBT) - - - - - -
Net income - - 27.29 - - -
Net margin - - 6.48% - - -
EPS - - - - - -
Dividend per Share - - - - - -
Announcement Date 26/08/21 12/11/21 13/05/22 26/08/22 26/08/22 11/11/22
1RON in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 513 592 596 1,097 1,054 - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) 3.429 x 2.637 x 1.933 x 4.317 x 3.672 x - - -
Free Cash Flow 1 60 45.4 127 -282 - 257 224 304
ROE (net income / shareholders' equity) 15.7% 25.6% 42.2% 11.1% -1.2% 4.5% 5.7% -
ROA (Net income/ Total Assets) 3.07% 4.88% - - - - - -
Assets 1 557.1 1,120 - - - - - -
Book Value Per Share 2 0.3500 0.4500 0.6400 0.7800 0.9400 0.9800 1.030 -
Cash Flow per Share 0.2100 0.2400 0.4300 - - - - -
Capex 1 50.7 80.3 87.2 160 - 75 75 75
Capex / Sales 5.24% 7.45% 6.09% 8.84% - 3.01% 2.7% -
Announcement Date 21/02/20 26/02/21 25/02/22 24/02/23 29/02/24 - - -
1RON in Million2RON
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
4.2 RON
Average target price
4.983 RON
Spread / Average Target
+18.65%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. M Stock
  4. Financials Med Life S.A.